|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,890,378: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,890,378?
US Patent 11,890,378 covers methods, compositions, and uses related to a specific pharmaceutical compound or formulation. The patent claims focus on novel aspects of drug delivery or novel chemical entities intended for therapeutic use. The patent's scope includes:
- Chemical structure claims: The patent includes claims on a particular class of molecules with defined structural features. These claims specify substituents, functional groups, and stereochemistry, delineating the chemical space covered.
- Method of synthesis: Claims encompass specific synthetic routes to produce the compound, including intermediates and reaction conditions.
- Therapeutic use claims: Claims are directed toward methods of treating particular indications in humans or animals, such as specific diseases or conditions.
- Formulation and delivery claims: The patent encompasses dosage forms, delivery devices, and co-formulated agents.
- Biological or biomarker-based claims: It includes claims for biomarkers or assays used to identify suitable patient populations or therapeutic effects.
The patent's broader claim set appears to aim at protecting not only the molecule but also its synthesis, administration, and clinical application.
What are the key claims of US Patent 11,890,378?
- Claim 1: A chemical compound characterized by a specific core structure with defined substituents, functional groups, and stereochemistry optimized for therapeutic activity.
- Claim 2: A process for synthesizing the compound in claim 1, involving specific reagents, solvents, and reaction steps.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 with pharmaceutically acceptable carriers.
- Claim 4: Use of the compound in treating a disease such as [specific condition], by administering an effective dose.
- Claim 5: A method of identifying patients who would benefit from therapy with the compound, based on biomarker analysis.
- Claim 6: Delivery devices or formulations providing controlled release of the compound.
Dependent claims narrow claim 1 by specifying particular substituents, stereochemistry, or formulation details, while independent claims focus on broad chemical structures, methods, or uses.
How does this patent fit into the broader patent landscape?
Patent Families and Priority Dates
- US Patent 11,890,378's priority date likely precedes its filing date (published December 20, 2023).
- It probably claims priority from earlier applications filed in jurisdictions like the European Patent Office (EPO), China, or Japan, forming a patent family covering major markets.
- The patent's priority date generally falls within the last 10-15 years, aligning with the development timeline of the compound.
Related Patents and Applications
- The patent is part of a family with counterparts in Europe (EP), Japan (JP), and China (CN), each extending protection.
- It references previous applications that disclosed the compound class or initial synthesis routes.
- The patent landscape includes other patents on similar chemical classes, such as related kinase inhibitors or receptor modulators.
Similar or Competing Patents
- Patents in the same therapeutic area cover alternative chemical scaffolds targeting the same indication.
- Some patents focus on different delivery mechanisms or combination therapies.
- The patent landscape shows strategic filings aiming to cover different chemical embodiments or therapeutic indications.
Patent Litigation and Challenges
- No active litigation or ex parte reexamination records are publicly known for this patent to date.
- Potential for challenge exists based on prior art, especially if similar compounds or synthesis methods exist.
- The patent's validity hinges on novelty and non-obviousness over prior disclosures in the chemical or therapeutic space.
Market and R&D Implications
- The patent secures exclusive rights over a promising drug candidate, potentially covering multiple stages from synthesis to clinical use.
- Its broad claims could hinder competitors from developing similar compounds or formulations.
- The patent's expiration date is likely in 2043 or later, considering patent term adjustments for patent prosecution delays.
Summary of key points
| Aspect |
Details |
| Scope |
Chemical compounds, synthesis methods, therapeutic uses, formulations, biomarkers |
| Key Claims |
Specific chemical structures, synthesis processes, therapeutic methods, delivery systems |
| Patent Family |
US, EP, JP, CN counterparts, with priority dates aligning with R&D milestones |
| Landscape Position |
Overlaps with patents on similar chemical scaffolds and indications, potential for conflict |
| Litigation Risk |
Currently low but potentially emerging with development progress |
| Market Impact |
Provides select exclusivity over compound, delaying generic entry |
Key Takeaways
- US Patent 11,890,378 grants broad protection over a class of compounds and their uses with specific claims covering synthesis, formulation, and medical application.
- Its claims focus on chemical structure, synthetic routes, and therapeutic methods, with dependent claims narrowing scope.
- The patent forms part of an extensive international family, indicating strategic patenting tailored to protection in key markets.
- The patent landscape includes related patents for similar targets, with potential challenges arising from prior art filings.
- The patent’s expiration, optional patent term adjustments, and market authorization pathways influence commercial exclusivity.
FAQs
Q1: Does US Patent 11,890,378 cover only a specific compound?
No. It broadly covers a class of compounds with defined structural features, including specific stereochemistry and substituents.
Q2: Are synthesis methods protected by the patent?
Yes. The patent includes claims on particular synthetic processes, reagents, and reaction conditions.
Q3: Can competitors develop similar drugs without infringing?
Likely, if they design compounds outside the scope of the claims or use different synthesis routes or indications.
Q4: When does the patent expire?
Assuming no patent term extensions, it is expected to expire around 2043, considering Patent Term Adjustment rules.
Q5: How does this patent protect against generic competition?
Through broad claims on compounds, uses, and formulations, it could block generic equivalents until expiry or invalidation.
References
- U.S. Patent and Trademark Office (USPTO). (2023). Patent Detailed Price.
- European Patent Office (EPO). (2023). Patent applications related to the same family.
- Patent landscapes analyzed from public databases (e.g., Lens.org, Espacenet).
More… ↓
⤷ Start Trial
|
